Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial.
Rial-Crestelo M, Lubusky M, Parra-Cordero M, Krofta L, Kajdy A, Zohav E, Ferriols-Perez E, Cruz-Martinez R, Kacerovsky M, Scazzocchio E, Roubalova L, Socias P, Hašlík L, Modzelewski J, Ashwal E, Castellá-Cesari J, Cruz-Lemini M, Gratacos E, Figueras F; RATIO37 Study Group. Rial-Crestelo M, et al. Among authors: socias p. Lancet. 2024 Feb 10;403(10426):545-553. doi: 10.1016/S0140-6736(23)02228-6. Epub 2024 Jan 11. Lancet. 2024. PMID: 38219773 Clinical Trial.
Effect of Maternal and Fetal Characteristics in Feto-Placental Doppler and Impact of Using Adjusted Standards in the Definition of Fetal Growth Restriction at Term.
Rial-Crestelo M, Velasco-Santiago AR, Lubusky M, Hermanova K, Kajdy A, Modzelewski J, Krofta L, Vojtech J, Ferriols-Pérez E, Rueda-García C, Parra-Cordero M, Socias P, Zohav E, Cruz-Lemini M, Gratacos E, Figueras F. Rial-Crestelo M, et al. Among authors: socias p. Fetal Diagn Ther. 2021;48(8):596-602. doi: 10.1159/000518093. Epub 2021 Sep 7. Fetal Diagn Ther. 2021. PMID: 34515108 Clinical Trial.
Prescriptive Reference Standards of Third-Trimester Cerebroplacental Ratio and Its Physiological Determinants.
Rial-Crestelo M, Garcia-Otero L, Cancemi A, Giannone M, Escazzocchio E, Biterna A, Ferriols E, Hernandez JL, Lubusky M, Kolarova V, Krofta L, Vojtêch J, Zohav E, Krajden K, Cruz-Martinez R, Cruz-Lemini M, Parra-Cordero M, Socias P, Crispi F, Lopez M, Gratacós E, Figueras F; Ratio 37 study group. Rial-Crestelo M, et al. Among authors: socias p. Fetal Diagn Ther. 2020 Jul 14:1-8. doi: 10.1159/000508366. Online ahead of print. Fetal Diagn Ther. 2020. PMID: 32663828
Revealed versus concealed criteria for placental insufficiency in an unselected obstetric population in late pregnancy (RATIO37): randomised controlled trial study protocol.
Figueras F, Gratacos E, Rial M, Gull I, Krofta L, Lubusky M, Cruz-Martinez R, Cruz-Lemini M, Martinez-Rodriguez M, Socias P, Aleuanlli C, Cordero MCP. Figueras F, et al. Among authors: socias p. BMJ Open. 2017 Jun 15;7(6):e014835. doi: 10.1136/bmjopen-2016-014835. BMJ Open. 2017. PMID: 28619771 Free PMC article. Clinical Trial.